Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Recruiting 7Completed 4Active not recruiting 4Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Thoracic 1Classical hematology 1

Conditions

Glioblastoma 2Carcinoma, Non-Small-Cell Lung 1Anemia 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 252Magnetic Resonance Spectroscopy 244Cyclophosphamide 240Cisplatin 213Paclitaxel 206Radiotherapy 195Biopsy 171Gemcitabine 155Dexamethasone 148durvalumab 143atezolizumab 126Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 111Radiation 109Docetaxel 103Pemetrexed 102Etoposide 101fludarabine 97venetoclax 95Fluorouracil 92Capecitabine 92Radiosurgery 90Prednisone 89Oxaliplatin 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Ascorbic Acid × 1 year × Clear all
NCT02905591 2026-03-25

XACT-LUNG

University of Iowa

Phase 2 Active not recruiting
43 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02344355 2025-12-12

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

University of Iowa

Phase 2 Active not recruiting
90 enrolled
CNS

Glioblastoma

NCT04900792 2025-12-03

XACT-Fe-GBM-01

University of Iowa

Phase 1 Active not recruiting
17 enrolled
CNS

Glioblastoma

NCT06018883 2025-08-07

PTCA199-3

Fudan University

Phase 3 Active not recruiting
100 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡